All News

Researchers found persistent and substantial delays between heart failure diagnosis and ATTR-CM identification.

White House projects $600B in savings from MFN drug pricing plan, with major implications for GLP-1 access, Medicaid, and biologics.

Eileen Ehret, BS, Navista, focuses on aligning quality improvement with patient safety, engaging all stakeholders, and creating safe spaces to drive change in oncology.

Panretinal laser photocoagulation was found to be inferior when compared with brolucizumab in patients with proliferative diabetic retinopathy.

A meta-analysis of 26 trials found that IV ketamine rapidly reduced suicidal and depressive symptoms in patients with major depressive episodes.

Cyberattacks could disrupt or delay patient care, making cybersecurity important to protecting patients in health care.

Katie Eyes, MSW, reflects on 25 years of the BCBSNC Foundation and, over her 18 years with the organization, its shift toward upstream, systems-level health solutions.

Shara Bialo, MD, emphasizes the crucial role of school nurses in early detection of type 1 diabetes.

Loss of a partner or sibling during the pandemic was associated with heightened cardiovascular vulnerability, according to one study.

Hospital at home is linked to lower mortality and ED use vs inpatient care in Medicare patients.

Bepirovirsen data show the potential for a functional cure for chronic hepatitis B by lowering HBsAg and boosting immune control.

988 crisis centers face staffing and funding challenges despite rising demand, raising concerns about long-term sustainability.

As president of the BCBSNC Foundation, Colleen Briggs, MBA, reflects on 25 years of progress and outlines where the organization is headed next.

Carolina Barnett-Tapia, MD, PhD, discusses the results of the ADAPT OCULUS trial, which found promising results for treating patients with ocular myasthenia gravis.

New executive order fast-tracks psychedelic therapy research for veterans, but VA rollout, DEA rescheduling, and insurance hurdles still loom.

These indications cover HIV, type 1 diabetes, chronic hives, genetic-related hearing loss, and lupus.

Data stored in hospitals, clinics, and medical practices make it a prime target for cyberattacks, making security important for continuity of care.

The Supreme Court temporarily restores mifepristone mail access, pausing a Fifth Circuit ruling that had blocked telehealth abortion pill prescriptions.

Poor housing affordability and quality raised risks of frailty, disability, and death in older adults, yet neighborhood quality showed no independent association.

This FDA approval brings the first heterobifunctional protein degrader for HER2-negative, ESR1-mutant breast cancer, improving PFS after endocrine therapy.

Experts dismantled the assumption that direct-to-patient is a universal affordability solution, offering manufacturers a practical framework for deciding which model is actually right.

Philadelphia oncology leaders tackle gaps in biomarker testing, breast cancer advances, myeloma innovation, and clinical trial equity.

New data show how systemic inflammation independently raises the risk of CKD progression and cardiovascular events after acute myocardial infarction.

This week, a Capitol hearing spotlights Medicare fraud gaps, reports warn of equity setbacks, community oncology boosts survival, and Medicaid work rules loom.

AI drives community oncology transformation as practice leaders offer examples of what is working in community oncology to streamline calls, triage, and documentation.

Rani Bansal, MD, discusses breast cancer subtypes, racial disparities in triple-negative disease, self-advocacy for young patients, and diversity in clinical trials.

The therapy receives FDA approval for Alzheimer disease agitation, backed by phase 3 data showing significant symptom reduction and delayed relapse vs placebo.

Experts at AXS26 laid out why advanced therapies are underutilized and what payers, providers, and manufacturers must do together to change that.